BioSpace News Archive

OcuSciences, Inc., a clinical-stage biotechnology company developing retinal imagers to detect early disease by assessing retinal metabolic activity, today announced the online publication of its diabetic macular edema study.

The Pharmaceutical Care Management Association (PCMA) today is announcing the additions of Amanda Frost as Assistant Vice President, Research and Tim Dube as Assistant Vice President, Regulatory Affairs. PCMA is also announcing new roles for Kristin Bass and Brian McCarthy.

HydRx Farms Ltd. (o/a Scientus Pharma) (“Scientus” or the “Company”), a biopharmaceutical company conducting research and product development for extracts and formulations related to medical cannabinoids and their derivatives, is pleased to announce that it has received authorization under the Cannabis Regulations granting sale of cannabis for medical purposes a

Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 37th Annual J. P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 11:30 am PT / 2:30 pm ET. Gerrit Klaerner, Ph.D., Tricida’s chief executive officer and president, will provide a company overview, business update and progress on the company’s key initiatives.

Proven Commercial Execution Selected for CEO Role; Seasoned Operational Expertise Selected for COO Role

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 2019 J.P. Morgan Healthcare Conference in San Francisco.

Akebia Therapeutics, Inc. granted six newly-hired employees options to purchase an aggregate of 45,150 shares of Akebia’s common stock on December 31, 2018, as inducements material to each such employee’s entering into employment with Akebia.

Crestline Direct Lending, a part of the opportunistic investment group of Crestline Investors, Inc. (“Crestline”), is pleased to announce the recent closing of a Senior Secured Credit Facility (the “Facility”) to support Schweiger Dermatology Group’s (“SDG” or the “Company”) rapid expansion as one of the leading providers of dermatology services in northeast United States.

Universal Display Corporation today announced its participation in the following investor conferences:

Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced the appointment of Philip M. Brown, M.D., J.D., as Chief Medical Officer.